---
schema_version: "secwatch.filing_event.v1"
accession: "0000917520-23-000079"
form_type: "8-K"
ticker: "IART"
cik: "0000917520"
company_name: "INTEGRA LIFESCIENCES HOLDINGS CORP"
filed_at: "2023-12-13T23:59:59+00:00"
generated_at: "2026-06-07T13:54:07.083833+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.3
calibrated_materiality_score: 0.3
confidence: "high"
source: SEC EDGAR
---

# Integra LifeSciences appoints Jeff Graves to board; adopts exec severance program

## Summary
- Jeffrey Alan Graves, CEO of 3D Systems, appointed to board effective Dec 12, 2023, filling an existing vacancy.
- Graves is independent; will receive pro-rated annual retainer and director equity grants under standard policy.
- Change in control severance program adopted effective Jan 1, 2024, covering CFO Lea Knight and other named executives.
- Program provides lump sum of 1.5x (2x for CFO) base salary plus target bonus, COBRA, and outplacement upon qualifying termination.
- Program expires Dec 31, 2024, but automatically extends for two years upon a change in control.

## SEC filing metadata
- accession: 0000917520-23-000079
- form_type: 8-K
- ticker: IART
- cik: 0000917520
- company_name: INTEGRA LIFESCIENCES HOLDINGS CORP
- filed_at: 2023-12-13T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.3
- calibrated_materiality_score: 0.3
- confidence: high
- sec_items: 5.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/917520/000091752023000079/0000917520-23-000079-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/917520/000091752023000079/iart-20231212.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000917520-23-000079
- JSON: https://secwatch.observer/filing/0000917520-23-000079.json
- Plain text: https://secwatch.observer/filing/0000917520-23-000079.txt

## Key facts
- Executive change
  Jeffrey Alan Graves was appointed as Director at INTEGRA LIFESCIENCES HOLDINGS CORP.
  - Action: appointed
  - Role: Director
  source text: On December 12, 2023, the Board of Directors (“Board”) of Integra LifeSciences Holdings Corporation (the “Company”), upon the recommendation of the Nominating and Corporate Governance committee of the Board, appointed Jeffrey Alan Graves as a director of the Company, effective immediately, to fill an existing vacancy on the Board.
  evidence_url: https://www.sec.gov/Archives/edgar/data/917520/000091752023000079/0000917520-23-000079-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.